Biotech · Private company · Atlanta, GA, US
Airway Therapeutics, Inc.
Track this companyFree. Adds Airway Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Air-shamPhase 1 · Bronchopulmonary DysplasiaClinicalTrials.gov · fetched Nov 12, 2026
- AT-100Phase 1 · Bronchopulmonary DysplasiaClinicalTrials.gov · fetched Nov 12, 2026
- AT-100Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)PHASE1 · COMPLETED · started Sep 1, 2021ClinicalTrials.gov NCT04662151 · fetched Nov 12, 2026
- A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired PneumoniaPHASE1 · TERMINATED · started Aug 17, 2021ClinicalTrials.gov NCT04659122 · fetched Nov 12, 2026
NIH awards1
- A Randomized,Phase 2b/3 Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preventing BPD in High-Risk Preterm Neonates Compared to Standard of Care.Fiscal year 2026 · $1.9MNIH RePORTER 1R44HL186892-01 · fetched Nov 12, 2026